{"id":"tp-53540","type":"article-newspaper","title":"FDA Approves Bayer's Sunharbo to Reduce Stroke Risk After Ischemic Events","author":"Riza Dagoc","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/regulation/53540","datePublished":"2026-11-11T03:49:56.000Z","dateModified":"2026-11-11T03:49:56.000Z","language":"en","abstract":"The once-daily drug reduced ischemic stroke risk by 26% in a Phase 3 trial. Major bleeding rates were similar overall, with increases in some groups.","section":"Regulation","references":[]}